All Posts: cancer
-
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.
Category: News Release
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
A team of researchers led by Georgetown Lombardi Comprehensive Cancer Center has published a study that indicates that the most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought.
Category: News Release
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: GUMC Stories
-
Soy, Cruciferous Vegetables Associated with Fewer Common Side Effects of Breast Cancer Treatment
Consuming soy foods and cruciferous vegetables may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, according to a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
New Test Provides Accurate Measure of DNA Damage from Chemical Compounds
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Category: News Release
-
31st Annual Lombardi Gala Raises $1.4 Million
Close to 700 Georgetown Lombardi Comprehensive Cancer Center supporters turned out for the 31st annual Lombardi Gala in Washington on November 18 as the cancer center honored a philanthropist, a researcher and a broadcast journalist.
Category: GUMC Stories
-
MedStar Health Taps Louis M. Weiner, MD, to Lead MedStar Georgetown Cancer Institute
MedStar Health has named Louis M. Weiner, MD, as director of its MedStar Georgetown Cancer Institute. Weiner will serve in this capacity while also remaining director of Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Bryant Gumbel Named 2017 NFL Players Association Georgetown Lombardi Award Recipient
Emmy Award-winning television journalist and sportscaster Bryant Gumbel has been named this year’s recipient of the NFL Players Association Georgetown Lombardi Award.
Category: News Release
-
CBCC Honors Patient Navigation Pioneer at Gift of Life Breakfast
(October 17, 2017) — At the 10th Annual Gift of Life breakfast, more than 200 supporters of the Capital Breast Care Center gathered at the Renaissance Washington, DC Downtown Hotel to celebrate the community-based program and its mission — providing patient navigation services and access to breast cancer screenings to all women, regardless of their […]
Category: GUMC Stories